Search by Drug Name or NDC
NDC 50090-1336-00 APLISOL 5 [iU]/.1mL Details
APLISOL 5 [iU]/.1mL
APLISOL is a INTRADERMAL INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is TUBERCULIN PURIFIED PROTEIN DERIVATIVE.
Product Information
| NDC | 50090-1336 |
|---|---|
| Product ID | 50090-1336_d703ef2b-e51b-4d20-990b-3dd4161629a0 |
| Associated GPIs | 94300070002010 |
| GCN Sequence Number | 009700 |
| GCN Sequence Number Description | tuberculin,purif.prot.deriv. VIAL 5 T/0.1 ML INTRADERM |
| HIC3 | W7T |
| HIC3 Description | ANTIGENIC SKIN TESTS |
| GCN | 44051 |
| HICL Sequence Number | 004227 |
| HICL Sequence Number Description | TUBERCULIN, PURIFIED PROTEIN DERIVATIVE |
| Brand/Generic | Generic |
| Proprietary Name | APLISOL |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tuberculin Purified Protein Derivative |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRADERMAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | [iU]/.1mL |
| Substance Name | TUBERCULIN PURIFIED PROTEIN DERIVATIVE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103782 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-1336-00 (50090133600)
| NDC Package Code | 50090-1336-0 |
|---|---|
| Billing NDC | 50090133600 |
| Package | 1 VIAL in 1 CARTON (50090-1336-0) / 1 mL in 1 VIAL |
| Marketing Start Date | 2014-11-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |